Overview

Fentanyl Patch Pharmacokinetics in Healthy Adults

Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery comparisons between RLD (reference listed drug) Duragesic ® TDDS (transdermal drug delivery system) and Generic Fentanyl TDDS in healthy adults and to ensure safety of individuals utilizing these types of products.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland
University of Maryland, Baltimore
Collaborator:
Food and Drug Administration (FDA)
Treatments:
Citric Acid
Fentanyl